Last reviewed · How we verify
Sham Procedure
The Sham Procedure is a placebo treatment with no active pharmaceutical ingredient.
The Sham Procedure is a placebo treatment with no active pharmaceutical ingredient. Used for Various conditions.
At a glance
| Generic name | Sham Procedure |
|---|---|
| Also known as | suprachoroidal sham |
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
It serves as a control group in clinical trials to compare the efficacy of active treatments. The Sham Procedure typically mimics the administration of an actual treatment, but without any therapeutic effect.
Approved indications
- Various conditions
Common side effects
- No adverse events reported
Key clinical trials
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- The Effects of 5G Radiation on Skin (NA)
- New York Better Breathing Study (NA)
- Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children (NA)
- Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant (PHASE3)
- Tetris Intervention Following Subliminal Reactivation for Intrusive Memories (NA)
- Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction (NA)
- A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sham Procedure CI brief — competitive landscape report
- Sham Procedure updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI